An aggressive research and development program is central to Bristol-Myers Squibb’s high valuation.
Sluggish manufacturing activity could prompt the Fed to raise interest rates at a slower-than-expected pace in 2016.
Congress sought to limit the Fed’s discretion to make bailout loans. But the final rule still leaves the central bank a lot of leeway.
The ECB is set to deliver looser policy this week. But the real answer to the eurozone’s sluggishness probably lies elsewhere.
Chinese nationals are the top foreign buyers of U.S. homes, but in recent weeks they have started to pull back, scared off by their country’s stock slump and weakening economy.
Aberdeen Asset Management is cutting costs to help margins. But its reliance on emerging markets equities means more pressure on the group.
An economic slowdown, a declining currency and stock market gyrations may finally be catching up with Chinese travelers’ plans to venture abroad.
It’s tough for investors in retail stocks to go on a buying spree. They want consistency even though teen retailers’ customers are notoriously fickle.
Christmas markets across Europe are seeing a decline in attendance amid security fears following the Paris attacks.
Wall Street Journal personal-finance columnist Jason Zweig’s new book, “The Devil’s Financial Dictionary,” is a satirical glossary of investing terms.